Reference
Osawa Y, et al. Posterior reversible encephalopathy syndrome after lenvatinib therapy in a patient with anaplastic thyroid carcinoma. Internal Medicine 57: 1015-1019, No. 7, Apr 2018. Available from: URL: http://doi.org/10.2169/internalmedicine.9593-17 - Japan
Rights and permissions
About this article
Cite this article
Lenvatinib. Reactions Weekly 1700, 161 (2018). https://doi.org/10.1007/s40278-018-45733-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45733-x